Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter
CU Ophthalmology Researcher Awarded Funding to Further Study Uveitis and Ocular Inflammation CU Anschutz newsroom Source: Author: | Date: 2024-09-09 07:00:00 Source: Author: | Date: 2024-09-09 07:00:00
Ophthalmology Innovator Joins NYU Langone Health as Chief of Oculoplastics NYU Langone Health Source: Author: | Date: 2024-09-06 07:00:00 Source: Author: | Date: 2024-09-06 07:00:00
Michaël J. A. Girard, PhD Emory School of Medicine Source: Author: | Date: 2024-08-23 05:43:00 Source: Author: | Date: 2024-08-23 05:43:00
Photobiomodulation use in ophthalmology – an overview of translational research from bench to bedside Frontiers Source: Author: | Date: 2024-08-15 06:23:00 Source: Author: | Date: 2024-08-15 06:23:00

Osheru announced the successful completion of a $4.7 million funding round aimed at accelerating the development and commercialization of its Ziplyft device for blepharoplasty surgery. The funding round was oversubscribed and led by a consortium of investors including individuals, family…

New research from Edith Cowan University (ECU) is shedding light on the factors driving the metastasis of uveal melanoma, the deadliest form of eye cancer known for its high rate of spreading to the liver. Uveal Melanoma Overview and Metastasis…

Samsara Vision announced the successful completion of the first SING IMT (Smaller-Incision New-Generation Implantable Miniature Telescope) procedure in China. This milestone was achieved at the First Affiliated Hospital of Hainan Medical University Lecheng Hospital, where Professor Li Xiaorong, MD, PhD,…

Topcon Healthcare, in collaboration with Orbis International and the Rwanda International Institute of Ophthalmology (RIIO), has embarked on an initiative to enhance diabetic retinopathy screening in Rwanda. Donation of Robotic Retinal Cameras To facilitate this effort, Topcon has generously donated…
Meet Wilmer’s Ophthalmic Residency Class of 2027 Johns Hopkins Medicine Source: Author: | Date: 2024-07-23 07:00:00 Source: Author: | Date: 2024-07-23 07:00:00

Genentech and Roche released compelling 2-year data from the phase 3 Pagoda and Pavilion studies evaluating Susvimo (ranibizumab injection) 100 mg/mL, marking a significant development in the treatment landscape for diabetic macular edema (DME) and diabetic retinopathy (DR). Reintroduction of…